Natural killer (NK) cells are the primary effector cells of the innate immune system and have well-established roles in tumor rejection and resistance to viruses, bacteria and certain parasites. There is a need for more specific immune modulators of NK cell activity that lack the wide-ranging side effects of NK cell-stimulatory interleukins. The polycationic antibiotic polymyxin B (PMB) has been shown to have a unique ability to enhance activities of some immune cells, independent of its antibiotic properties. Here we report that both PMB and its analog polymyxin E (PME) markedly enhanced the activity of NK cells enriched from the murine spleen. Maximal activation of NK cell activity was obtained after 24 h of incubation with PMB at a dose of 300 μg/ml. PMB nonapeptide, one of the two PMB domains, and PME methanesulfonate, the negatively charged derivative of PME, had little effect on NK cell activity. PMB induced interferon (IFN)-γ and tumor necrosis factor-α production in NK cells.
Introduction
Natural killer (NK) cells are the primary effector cells of the innate immune system and have well-established roles in tumor rejection in a variety of spontaneous and induced cancer models and resistance to viruses, bacteria and certain parasites [1] [2] [3] [4] [5] [6, 7] . Clinical trials to enhance the anti-tumor potential of NK cells and the innate immune system have been performed over the last decade [8] . However, systemic administration of cytokines that regulate NK cell proliferation and/or activation perturb complex regulatory pathways, and serious side effects, including hypertension, cachexia, fever, chills, vomiting and diarrhea, have been observed [9] [10] [11] . There is an obvious need for more specific immune modulators that lack the wide-ranging side effects of the cytokines currently found in the clinical trials.
Polymyxins B and E, which consist of a polycationic decapeptide and a fatty acid residue linked by an amide bond, show antibiotic activity against a diverse array of organisms, including bacteria, yeasts, and protozoa [12, 13] . Polymyxin B (PMB) is especially active in causing permeabilization and killing of Gram-negative bacteria and has therefore been used for treating certain bacterial infections. Membrane disruption of the bacteria appears to be induced by interaction between PMB and bacterial phospholipids and lipopolysaccharide (LPS) in the outer membrane [12] . The high affinity of PMB for LPS is currently exploited to remove contaminating LPS from solutions and reagents, thus avoiding endotoxin shock or excluding the presence of potential LPS contaminations in experimental systems [14] . In addition to its abilities to neutralize LPS and kill microbes, PMB has been shown to enhance activities of some immune cells: it activated B cells [15] , induced maturation of monocyte-derived dendritic cells [16] , and enhanced immunostimulatory sequence-induced IFN-α production in plasmacytoid dendritic cells [17] . Prompted by these reports indicating direct activity of PMB on innate immune cells, we examined the effect of PMB on activity of NK cells, the primary effector cells of the innate immune system. We found in this study that PMB remarkably enhanced murine NK cell cytolytic activity both in vitro and in vivo.
Materials and methods
PMB sulfate salt, polymyxin E (PME, also known as colistin) sulfate salt, PME sodium methanesulfonate, and PMB nonapeptide hydrochloride were obtained from Sigma Chemical 
Results and discussion
NK cells enriched by negative selection were incubated with PMB for 24 h, and their cytotoxic acitivity against YAC-1 target cells was assayed. NK cell activity was enhanced in a dose-dependent manner by 30−300 μg/ml of PMB (Fig. 1A) . The effective concentrations are comparable to those previously reported for B cells and dendritic cells [15] [16] [17] . Maximal effect of PMB was observed at the concentration of 300 μg/ml, inducing a 7-fold increase in NK cell activity (Fig. 1A) and as marked as the effect of 5 U/ml of IL-2 (Fig. 1C) . The activity of NK cells purified by negative plus positive selection was similarly enhanced by PMB (Fig. 1A) . Incubation for 24 h or more was necessary for the full enhancing effect (Fig.   1B) . PME, in which D-phenylalanine of PMB cyclic peptide is replaced by D-leucine, was also effective (Fig. 1C) . Both PMB and PME have two major domains: a polycationic decapeptide domain containing a heptapeptide ring and a fatty acid residue linked by an amide bond. In order to determine whether one or both domains are required to stimulate NK 6 cell activity, PMB nonapeptide and PME methanesulfonate were employed. PMB nonapeptide lacks the hydrophobic tail but retains the positively charged cyclic peptide domain. PME methanesulfonate is negatively charged instead of being positively charged, but the hydrophobic tail is intact. Neither PMB nonapeptide nor PME methanesulfonate had a notable effect on NK activity (Fig. 1C) .
It is known that IFN-γ is a key cytokine during innate and adaptive immune responses, and activated NK cells and T cells, which are the major types of innate and adaptive immune cells, respectively, produce IFN-γ [21, 22] . We examined whether IFN-γ production is up-regulated in NK cells cultured with PMB and PME. As shown in Fig. 2A , both PMB and PME enhanced IFN-γ production as markedly as did 5 U/ml of IL-2. NK cells can produce TNF-α, and production of this cytokine is increased by activation with IL-2 [23, 24] . PMB also enhanced TNF-α production as potently as did 5 U/ml of IL-2 in NK cells enriched by negative selection (Fig. 2B ) and in NK cells purified by negative plus positive selection (data not shown). There were a very few dendritic cells in the both NK cell preparations purified by negative selection only and negative plus positive selection (less than 0.5% and 0.1%, respectively). Neither IFN-α nor IL-12 was detected in the culture supernatants of NK cells incubated with or without PMB (data not shown).
In order to examine the in vivo effect of PMB on NK activity, mice were intraperitoneally administered PMB for 7 consecutive days, and NK activities of their splenocytes were determined. The splenic NK activity in mice treated with PMB significantly increased at all of the three different effector:target ratios (Fig. 3) . PMB had no significant effect on body weight gain of mice during the experimental periods (data not shown). NK cell populations also significantly increased in the mice treated with PMB, as determined by flow cytometry ( Fig.   4A and 4B) . Proliferation of NK cells in vitro was measured by being labeled with (Fig. 4C) .
PMB has been used due to its high affinity for LPS and being devoid of pleiotropic effects to exclude the presence of potential contaminations of LPS, a potent activator of innate 7 immune cells, in experimental systems. However, recent studies have shown that PMB is capable of directly activating some functions of dendritic cells [16, 17] . We demonstrated in this study that PMB activated murine NK cells, the primary effector cells of the innate immune system, to kill tumor cells and produce IFN-γ and TNF-α at doses comparable to those effective on dendritic cells. To the best of our knowledge, this is the first report on the regulation of NK cell function by PMB. We also demonstrated stimulation of NK cell activity and proliferation by PMB administration in vivo.
The mechanism responsible for PMB-induced NK cell activation has not been elucidated, but our studies using derivatives of PMB and PME suggested that both polycationic peptide and hydrophobic tail domains of the polymyxins are required for promoting cytolytic activity of NK cells. The two domains of PMB confer on the antibiotic the amphipathic property of solubilizing in water or lipid membranes, which is necessary for optimal membrane disruption of Gram-negative bacteria induced by the antibiotic. In contrast, it has been reported that polyanions such as heparin and dextran sulfate inhibit NK activity [25] . PMB is known as an inhibitor of protein kinase C (PKC) [26] . This activity of PMB, however, may not be involved for the indicated periods with or without 300 μg/ml of PMB (B), and for 24 h with or without 5 U/ml of IL-2 or 300 μg/ml of each of PME, PME methanesulfonate, PMB nonapeptide, and PMB (C). NK cells purified by negative plus positive selection were also incubated for 24 h with or without 300 μg/ml of PMB ( 
